The revised EU GMP Annex 1 introduced a more comprehensive, risk-based approach to environmental monitoring in sterile manufacturing. The guidance became operational from 25 August 2023, with point 8.123 becoming applicable from 25 August 2024.
A key change is the stronger integration of environmental monitoring into the Contamination Control Strategy (CCS). Monitoring programmes should be scientifically justified through quality risk management, considering sampling locations, monitoring frequency, methods, and critical processing areas. The revised Annex 1 specifically covers total particle monitoring, viable particle and personnel monitoring, temperature, relative humidity, and other relevant environmental characteristics.
The requirements also place greater emphasis on detecting excursions, investigating results, analysing trends, and using monitoring data to support batch certification and ongoing process review. For pharmaceutical cleanrooms, this means environmental monitoring should be viewed as part of an integrated contamination-control system rather than simply a routine testing activity.
